Targeting serglycin prevents metastasis in murine mammary carcinoma

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Roy, Ananya ^a,b   Femel, Julia ^b   Huijbers, Elisabeth J M ^c   Spillmann, Dorothe ^b   Larsson, Erik ^d   Ringvall, Maria ^b   Olsson, Anna Karin ^b   Åbrink, Magnus ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOGLYCAN; SERGLYCIN; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; E-CADHERIN PROTEIN, MOUSE; VESICULAR TRANSPORT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER MODEL; CANCER TISSUE; CELL GROWTH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG TARGETING; FEMALE; GENE EXPRESSION; LUNG METASTASIS; MALE; METASTASIS INHIBITION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIMARY TUMOR; PROTEIN EXPRESSION; TUMOR INVASION; ANIMAL; EPITHELIAL MESENCHYMAL TRANSITION; EXPERIMENTAL MAMMARY NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; LUNG; LUNG TUMOR; METABOLISM; PATHOLOGY; SECONDARY; UPREGULATION;

ANIMALS; CADHERINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; LUNG; LUNG NEOPLASMS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; PROTEOGLYCANS; UP-REGULATION; VESICULAR TRANSPORT PROTEINS;

EID: 84971418614     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156151     Document Type: Article

References (58)

1. Schick BP, Gradowski JF, San Antonio JD. Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells. Blood. 2001; 97(2):449-58. Epub 2001/01/12. PMID: 11154222.
2. Keith Ho HC, McGrath KE, Brodbeck KC, Palis J, Schick BP. Serglycin proteoglycan synthesis in the murine uterine decidua and early embryo. Biol Reprod. 2001; 64(6):1667-76. Epub 2001/05/23. PMID: 11369593.
3. Schick BP, Ho HC, Brodbeck KC, Wrigley CW, Klimas J. Serglycin proteoglycan expression and synthesis in embryonic stem cells. Biochim Biophys Acta. 2003; 1593(2-3):259-67. Epub 2003/02/13.PMID: 12581870.
4. Pejler G, Abrink M, Wernersson S. Serglycin proteoglycan: regulating the storage and activities of hematopoietic proteases. Biofactors. 2009; 35(1):61-8. Epub 2009/03/26. doi: 10.1002/biof.11 PMID: 19319847.
5. Meen AJ, Oynebraten I, Reine TM, Duelli A, Svennevig K, Pejler G, et al. Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/ CXCL1. J Biol Chem. 2011; 286(4):2636-47. Epub 2010/11/16. doi: 10.1074/jbc.M110.151944 PMID: 21075844; PubMed Central PMCID: PMC3024759.
6. Abrink M, Grujic M, Pejler G. Serglycin is essential for maturation of mast cell secretory granule. J Biol Chem. 2004; 279(39):40897-905. Epub 2004/07/03. doi: 10.1074/jbc.M405856200 PMID: 15231821.
7. Niemann CU, Abrink M, Pejler G, Fischer RL, Christensen EI, Knight SD, et al. Neutrophil elastase depends on serglycin proteoglycan for localization in granules. Blood. 2007; 109(10):4478-86. Epub 2007/02/03. doi: 10.1182/blood-2006-02-001719 PMID: 17272511.
8. Sawesi O, Spillmann D, Lunden A, Wernersson S, Abrink M. Serglycin-independent release of active mast cell proteases in response to Toxoplasma gondii infection. J Biol Chem. 2010; 285(49):38005-13.Epub 2010/09/25. doi: 10.1074/jbc.M110.118471 PMID: 20864536; PubMed Central PMCID: PMC2992234.
9. Ringvall M, Ronnberg E, Wernersson S, Duelli A, Henningsson F, Abrink M, et al. Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan. J Allergy Clin Immunol. 2008; 121(4):1020-6. Epub 2008/02/01. doi: 10.1016/j.jaci.2007.11.031 PMID: 18234316.
10. Zernichow L, Abrink M, Hallgren J, Grujic M, Pejler G, Kolset SO. Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-alpha secretion in response to lipopolysaccharide. J Biol Chem. 2006; 281(37):26792-801. Epub 2006/06/ 30. doi: 10.1074/jbc.M512889200 PMID: 16807245.
11. Grujic M, Christensen JP, Sorensen MR, Abrink M, Pejler G, Thomsen AR. Delayed contraction of the CD8+ T cell response toward lymphocytic choriomeningitis virus infection in mice lacking serglycin. J Immunol. 2008; 181(2):1043-51. Epub 2008/07/09. PMID: 18606656.
12. Wernersson S, Braga T, Sawesi O, Waern I, Nilsson KE, Pejler G, et al. Age-related enlargement of lymphoid tissue and altered leukocyte composition in serglycin-deficient mice. J Leukoc Biol. 2009; 85 (3):401-8. Epub 2008/12/18. doi: 10.1189/jlb.1008670 PMID: 19088175.
13. Theocharis AD, Seidel C, Borset M, Dobra K, Baykov V, Labropoulou V, et al. Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro. J Biol Chem. 2006; 281(46):35116-28. Epub 2006/07/28. doi: 10.1074/jbc.M601061200 PMID: 16870619.
14. Niemann CU, Kjeldsen L, Ralfkiaer E, Jensen MK, Borregaard N. Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK. 2007; 21(12):2406-10. Epub 2007/10/12. doi: 10. 1038/sj.leu.2404975 PMID: 17928883.
15. Li XJ, Ong CK, Cao Y, Xiang YQ, Shao JY, Ooi A, et al. Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis. Cancer Res. 2011; 71(8):3162-72. Epub 2011/02/04. doi: 10.1158/0008-5472.CAN-10-3557 PMID: 21289131.
16. Korpetinou A, Skandalis SS, Moustakas A, Happonen KE, Tveit H, Prydz K, et al. Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells. PLoS One. 2013; 8(10):e78157.Epub 2013/11/10. doi: 10.1371/journal.pone.0078157 PMID: 24205138; PubMed Central PMCID: PMC3815026.
17. Purushothaman A, Toole BP. Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization. J Biol Chem. 2014; 289(9):5499-509. Epub 2014/01/10. doi: 10.1074/ jbc.M113.532143 PMID: 24403068; PubMed Central PMCID: PMC3937626.
18. Skliris A, Happonen KE, Terpos E, Labropoulou V, Borset M, Heinegard D, et al. Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma. Eur J Immunol. 2011; 41(2):437-49. Epub 2011/01/27. doi: 10.1002/eji.201040429 PMID: 21268013.
19. Toyama-Sorimachi N, Kitamura F, Habuchi H, Tobita Y, Kimata K, Miyasaka M. Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells. J Biol Chem. 1997; 272(42):26714-9. Epub 1997/10/23. PMID: 9334256.
20. Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer. 2011; 11(4):254-67. Epub 2011/03/11. doi: 10.1038/nrc3023 PMID: 21390059.
21. Skliris A, Labropoulou VT, Papachristou DJ, Aletras A, Karamanos NK, Theocharis AD. Cell-surface serglycin promotes adhesion of myeloma cells to collagen type I and affects the expression of matrix metalloproteinases. Febs J. 2013; 280(10):2342-52. Epub 2013/02/08. doi: 10.1111/febs.12179 PMID: 23387827.
22. Smith HA, Kang Y. The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl). 2013; 91(4):411-29. Epub 2013/03/22. doi: 10.1007/s00109-013-1021-5 PMID: 23515621; PubMed Central PMCID: PMC3697909.
23. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992; 12(3):954-61. Epub 1992/03/01. PMID: 1312220; PubMed Central PMCID: PMC369527.
24. Ullman-Cullere MH, Foltz CJ. Body condition scoring: a rapid and accurate method for assessing health status in mice. Lab Anim Sci. 1999; 49(3):319-23. Epub 1999/07/14. PMID: 10403450.
25. Ledin J, Staatz W, Li JP, Gotte M, Selleck S, Kjellen L, et al. Heparan sulfate structure in mice with genetically modified heparan sulfate production. J Biol Chem. 2004; 279(41):42732-41. Epub 2004/08/ 05. doi: 10.1074/jbc.M405382200 PMID: 15292174.
26. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A. 2001; 98(1):31-6. Epub 2001/01/03. doi: 10.1073/pnas.011404098 PMID: 11134512; PubMed Central PMCID: PMC14539.
27. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990; 9 (7):811-8. Epub 1990/07/01. PMID: 2218183.
28. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. Epub 2009/01/10. doi: 10.1038/nprot. 2008.211 PMID: 19131956.
29. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009; 37(1):1-13. Epub 2008/11/27. doi: 10.1093/nar/gkn923 PMID: 19033363; PubMed Central PMCID: PMC2615629.
30. Sturn A, Quackenbush J, Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics. 2002; 18(1):207-8. Epub 2002/02/12. PMID: 11836235.
31. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev. 1994; 8(1):23-32. Epub 1994/01/01. PMID: 7507074.
32. Fantozzi A, Christofori G. Mouse models of breast cancer metastasis. Breast Cancer Res. 2006; 8 (4):212. Epub 2006/08/05. doi: 10.1186/bcr1530 PMID: 16887003; PubMed Central PMCID: PMC1779475.
33. Dwyer RM, Potter-Beirne SM, Harrington KA, Lowery AJ, Hennessy E, Murphy JM, et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res. 2007; 13(17):5020-7. Epub 2007/09/06. doi: 10.1158/1078-0432.CCR-07-0731 PMID: 17785552.
34. Yoshimura T, Howard OM, Ito T, Kuwabara M, Matsukawa A, Chen K, et al. Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PLoS One. 2013; 8(3):e58791. Epub 2013/03/26. doi: 10.1371/journal.pone.0058791 PMID: 23527025; PubMed Central PMCID: PMC3601078.
35. Korpetinou A, Skandalis SS, Labropoulou VT, Smirlaki G, Noulas A, Karamanos NK, et al. Serglycin: At the Crossroad of Inflammation and Malignancy. Front Oncol. 2014; 3:327. Epub 2014/01/24. doi: 10. 3389/fonc.2013.00327 PMID: 24455486; PubMed Central PMCID: PMC3888995.
36. Kolset SO, Pejler G. Serglycin: a structural and functional chameleon with wide impact on immune cells. J Immunol. 2011; 187(10):4927-33. Epub 2011/11/04. doi: 10.4049/jimmunol.1100806 PMID: 22049227.
37. Theocharis AD, Skandalis SS, Tzanakakis GN, Karamanos NK. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. Febs J. 2010; 277 (19):3904-23. Epub 2010/09/16. doi: 10.1111/j.1742-4658.2010.07800.x PMID: 20840587.
38. Afratis N, Gialeli C, Nikitovic D, Tsegenidis T, Karousou E, Theocharis AD, et al. Glycosaminoglycans: key players in cancer cell biology and treatment. Febs J. 2012; 279(7):1177-97. Epub 2012/02/16. doi: 10.1111/j.1742-4658.2012.08529.x PMID: 22333131.
39. Alderton GK. Metastasis: Epithelial to mesenchymal and back again. Nat Rev Cancer. 2013; 13(1):3.Epub 2012/12/22. doi: 10.1038/nrc3428 PMID: 23258155.
40. Tsai JH, Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013; 27 (20):2192-206. Epub 2013/10/22. doi: 10.1101/gad.225334.113 PMID: 24142872; PubMed Central PMCID: PMC3814640.
41. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol. 2003; 163(5):2113-26. Epub 2003/10/28. doi: 10.1016/S0002-9440(10)63568-7 PMID: 14578209; PubMed Central PMCID: PMC1892434.
42. Davie SA, Maglione JE, Manner CK, Young D, Cardiff RD, MacLeod CL, et al. Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice. Transgenic Res. 2007; 16(2):193-201. Epub 2007/01/09. doi: 10.1007/s11248-006-9056-9PMID: 17206489; PubMed Central PMCID: PMC1829418.
43. Le Voyer T, Rouse J, Lu Z, Lifsted T, Williams M, Hunter KW. Three loci modify growth of a transgeneinduced mammary tumor: suppression of proliferation associated with decreased microvessel density. Genomics. 2001; 74(3):253-61. Epub 2001/06/21. doi: 10.1006/geno. 2001.6562 PMID: 11414753.
44. Hunter K, Welch DR, Liu ET. Genetic background is an important determinant of metastatic potential. Nat Genet. 2003; 34(1):23-4; author reply 5. Epub 2003/05/02. doi: 10.1038/ng0503-23b PMID: 12721549.
45. Hu Y, Bai L, Geiger T, Goldberger N, Walker RC, Green JE, et al. Genetic background may contribute to PAM50 gene expression breast cancer subtype assignments. PLoS One. 2013; 8(8):e72287. Epub 2013/09/10. doi: 10.1371/journal.pone.0072287 PMID: 24015230; PubMed Central PMCID: PMC3756056.
46. Lifsted T, Le Voyer T, Williams M, Muller W, Klein-Szanto A, Buetow KH, et al. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer. 1998; 77(4):640-4. Epub 1998/07/29. PMID: 9679770.
47. Hamilton A, Basic V, Andersson S, Abrink M, Ringvall M. Loss of Serglycin Promotes Primary Tumor Growth and Vessel Functionality in the RIP1-Tag2 Mouse Model for Spontaneous Insulinoma Formation. PLoS One. 2015; 10(5):e0126688. Epub 2015/05/16. doi: 10.1371/journal.pone.0126688 PMID: 25978773; PubMed Central PMCID: PMC4433182.
48. He L, Zhou X, Qu C, Tang Y, Zhang Q, Hong J. Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients. Med Oncol. 2013; 30(4):707. Epub 2013/09/03. doi: 10. 1007/s12032-013-0707-4 PMID: 23996242.
49. Lundequist A, Abrink M, Pejler G. Mast cell-dependent activation of pro matrix metalloprotease 2: A role for serglycin proteoglycan-dependent mast cell proteases. Biol Chem. 2006; 387(10-11):1513-9.Epub 2006/11/04. doi: 10.1515/BC.2006.189 PMID: 17081126.
50. Woulfe DS, Lilliendahl JK, August S, Rauova L, Kowalska MA, Abrink M, et al. Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice. Blood. 2008; 111 (7):3458-67. Epub 2007/12/21. doi: 10.1182/blood-2007-07-104703 PMID: 18094327; PubMed Central PMCID: PMC2275015.
51. Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011; 11(2):123-34. Epub 2011/01/25. doi: 10.1038/nrc3004 PMID: 21258396.
52. Braga T, Grujic M, Lukinius A, Hellman L, Abrink M, Pejler G. Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells. Biochem J. 2007; 403(1):49-57. Epub 2006/12/07.doi: 10.1042/BJ20061257 PMID: 17147513; PubMed Central PMCID: PMC1828881.
53. Xue Y, Lim S, Yang Y, Wang Z, Jensen LD, Hedlund EM, et al. PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells. Nat Med. 2012; 18 (1):100-10. Epub 2011/12/06. doi: 10.1038/nm.2575 PMID: 22138754.
54. Iozzo RV, Sanderson RD. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med. 2011; 15(5):1013-31. Epub 2010/12/16. doi: 10.1111/j.1582-4934.2010.01236.x PMID: 21155971; PubMed Central PMCID: PMC3633488.
55. Theocharis AD, Skandalis SS, Neill T, Multhaupt HA, Hubo M, Frey H, et al. Insights into the key roles of proteoglycans in breast cancer biology and translational medicine. Biochim Biophys Acta. 2015; 1855(2):276-300. Epub 2015/04/02. doi: 10.1016/j.bbcan.2015.03.006 PMID: 25829250; PubMed Central PMCID: PMC4433619.
56. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003; 33(1):49-54. Epub 2002/12/07. doi: 10.1038/ng1060 PMID: 12469122.
57. Woelfle U, Cloos J, Sauter G, Riethdorf L, Janicke F, van Diest P, et al. Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res. 2003; 63(18):5679-84. Epub 2003/10/03. PMID: 14522883.
58. Daves MH, Hilsenbeck SG, Lau CC, Man TK. Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors. BMC Med Genomics. 2011; 4:56. Epub 2011/ 07/09. doi: 10.1186/1755-8794-4-56 PMID: 21736749; PubMed Central PMCID: PMC3212952.